Latest News

Large shareholder group calls for a board overhaul at pharma company CytoDyn

Paul Rosenbaum, CEO of SWR Corp., is no stranger to shareholder activism. He’s leading a group of investors calling for change at CytoDyn.

What is your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News